These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 12690223
1. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Aronowski J, Strong R, Shirzadi A, Grotta JC. Stroke; 2003 May; 34(5):1246-51. PubMed ID: 12690223 [Abstract] [Full Text] [Related]
2. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Piriyawat P, Labiche LA, Burgin WS, Aronowski JA, Grotta JC. Stroke; 2003 May; 34(5):1242-5. PubMed ID: 12690224 [Abstract] [Full Text] [Related]
3. Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Zhao X, Liu SJ, Zhang J, Strong R, Aronowski J, Grotta JC. Stroke; 2005 Jan; 36(1):129-34. PubMed ID: 15569874 [Abstract] [Full Text] [Related]
4. Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia. Martin-Schild S, Hallevi H, Shaltoni H, Barreto AD, Gonzales NR, Aronowski J, Savitz SI, Grotta JC. J Stroke Cerebrovasc Dis; 2009 Jan; 18(2):86-96. PubMed ID: 19251183 [Abstract] [Full Text] [Related]
5. Neuroprotective effect of acute ethanol administration in a rat with transient cerebral ischemia. Wang F, Wang Y, Geng X, Asmaro K, Peng C, Sullivan JM, Ding JY, Ji X, Ding Y. Stroke; 2012 Jan; 43(1):205-10. PubMed ID: 22052512 [Abstract] [Full Text] [Related]
6. Pharmacology of caffeinol in embolized rabbits: clinical rating scores and intracerebral hemorrhage incidence. Lapchak PA, Song D, Wei J, Zivin JA. Exp Neurol; 2004 Aug; 188(2):286-91. PubMed ID: 15246828 [Abstract] [Full Text] [Related]
7. [Caffeinol: a neuroprotective action in ischemic brain damage]. Bednarski J, Gasińska K, Straszewski T, Godek M, Tutka P. Przegl Lek; 2015 Aug; 72(11):677-81. PubMed ID: 27012130 [Abstract] [Full Text] [Related]
8. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model. Culp WC, Brown AT, Lowery JD, Arthur MC, Roberson PK, Skinner RD. Mol Neurobiol; 2015 Oct; 52(2):979-84. PubMed ID: 26055229 [Abstract] [Full Text] [Related]
9. Lost in translation: taking neuroprotection from animal models to clinical trials. Hoyte L, Kaur J, Buchan AM. Exp Neurol; 2004 Aug; 188(2):200-4. PubMed ID: 15246820 [Abstract] [Full Text] [Related]
10. Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats. Belayev L, Khoutorova L, Zhang Y, Belayev A, Zhao W, Busto R, Ginsberg MD. Brain Res; 2004 May 22; 1008(2):278-83. PubMed ID: 15145766 [Abstract] [Full Text] [Related]
11. Post-trauma administration of caffeine plus ethanol reduces contusion volume and improves working memory in rats. Dash PK, Moore AN, Moody MR, Treadwell R, Felix JL, Clifton GL. J Neurotrauma; 2004 Nov 22; 21(11):1573-83. PubMed ID: 15684650 [Abstract] [Full Text] [Related]
12. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. Alonso de Leciñana M, Gutiérrez M, Roda JM, Carceller F, Díez-Tejedor E. J Neurol Sci; 2006 Sep 25; 247(2):121-9. PubMed ID: 16797595 [Abstract] [Full Text] [Related]
13. Clinical and tissue response to intravenous thrombolysis in tandem internal carotid artery/middle cerebral artery occlusion: an MRI study. Thomalla G, Kruetzelmann A, Siemonsen S, Gerloff C, Rosenkranz M, Röther J, Fiehler J. Stroke; 2008 May 25; 39(5):1616-8. PubMed ID: 18323483 [Abstract] [Full Text] [Related]
14. Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine. Zhao X, Strong R, Piriyawat P, Palusinski R, Grotta JC, Aronowski J. Stroke; 2010 Feb 25; 41(2):363-7. PubMed ID: 20044532 [Abstract] [Full Text] [Related]
15. Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Strong R, Grotta JC, Aronowski J. Neuropharmacology; 2000 Jan 28; 39(3):515-22. PubMed ID: 10698017 [Abstract] [Full Text] [Related]
16. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model. Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D. Basic Clin Pharmacol Toxicol; 2015 Nov 28; 117(5):335-9. PubMed ID: 25899606 [Abstract] [Full Text] [Related]
17. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis. Reinhard M, Wihler C, Roth M, Harloff A, Niesen WD, Timmer J, Weiller C, Hetzel A. Cerebrovasc Dis; 2008 Nov 28; 26(2):147-55. PubMed ID: 18560218 [Abstract] [Full Text] [Related]
18. Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Gautier S, Petrault O, Gele P, Laprais M, Bastide M, Bauters A, Deplanque D, Jude B, Caron J, Bordet R. Stroke; 2003 Dec 28; 34(12):2975-9. PubMed ID: 14615621 [Abstract] [Full Text] [Related]
19. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats. Murakami K, Suzuki M, Suzuki N, Hamajo K, Tsukamoto T, Shimojo M. Brain Res; 2013 Aug 14; 1526():84-93. PubMed ID: 23791950 [Abstract] [Full Text] [Related]
20. Life after SAINT. Hallevi H, Aronowski J. Int J Stroke; 2007 Nov 14; 2(4):241-2. PubMed ID: 18705923 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]